Service d'ophtalmologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


10 publications

2024 | 2023 | 2022 | 2021 | 2020 |
2024
 
Clinical manifestations and immune markers of non-HIV-related CMV retinitis.
Passarin O., Hoogewoud F., Manuel O., Guex-Crosier Y., 2024/08/06. BMC infectious diseases, 24 (1) p. 787. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F3CE597735B]
2023
Differential roles of eNOS in late effects of VEGF-A on hyperpermeability in different types of endothelial cells.
Bosma E.K., Darwesh S., Habani Y.I., Cammeraat M., Serrano Martinez P., van Breest Smallenburg M.E., Zheng J.Y., Vogels IMC, van Noorden CJF, Schlingemann R.O. et al., 2023/12/05. Scientific reports, 13 (1) p. 21436. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_74E9695791E6]
Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects.
Garweg J.G., Blum C.A., Copt R.P., Eandi C.M., Hatz K., Prünte C.F., Seelig E., Somfai G.M., 2023/04. Ophthalmology and therapy, 12 (2) pp. 639-655. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A8A163A2B7E5]
Patient Perspective on the Monitoring of Their Wet Age-Related Macular Degeneration during Coronavirus Disease 2019: A Retrospective Study.
Tsiropoulos G.N., Vallée R., Calci C., Gallo Castro D., Ambresin A., 2023/03/02. Medicina, 59 (3) p. 490. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_132B4684385F]
2022
SUFU haploinsufficiency causes a recognisable neurodevelopmental phenotype at the mild end of the Joubert syndrome spectrum.
Serpieri V., D'Abrusco F., Dempsey J.C., Cheng Y.H., Arrigoni F., Baker J., Battini R., Bertini E.S., Borgatti R., Christman A.K. et al., 2022/09. Journal of medical genetics, 59 (9) pp. 888-894. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7731D4F15429]
2021
Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy.
Mbefo M., Berger A., Schouwey K., Gérard X., Kostic C., Beryozkin A., Sharon D., Dolfuss H., Munier F., Tran H.V. et al., 2021/08/28. International journal of molecular sciences, 22 (17) p. 9331. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CD3CAE19D3B7]
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B., Kastelein A.W., Klaassen I., Jansen CHJR, Latul Y.P., Vittori M., Biri A., Kahraman K., Griffioen A.W., Amant F. et al., 2021/01. Biochimica et biophysica acta. Reviews on cancer, 1875 (1) p. 188446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F5A67FD9048]
Neuro-Behavioral Correlates of Executive Dysfunctions in Dyslexia Over Development From Childhood to Adulthood.
Farah R., Ionta S., Horowitz-Kraus T., 2021. Frontiers in psychology, 12 p. 708863. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8BC9865FE007]
2020
 
3-Dimensional magnetic resonance imaging of the freely moving human eye.
Franceschiello B., Di Sopra L., Minier A., Ionta S., Zeugin D., Notter M.P., Bastiaansen JAM, Jorge J., Yerly J., Stuber M. et al., 2020/11. Progress in neurobiology, 194 p. 101885. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A712021E806E]
 
Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation.
Vaclavik V., Tran H.V., Schorderet Md PhD D.F., 2020/10. Ophthalmology. Retina, 4 (10) p. 1023. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4C6A535CC64F]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University